Upstream Bio, Inc. (UPB) Stock Profile — Insider Trades & Financials

Revenue$668.0K

Net Income-$42.5M

EPS$-0.78

Market Cap$445.3M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

E. Sutherland

CEO & Executive Director

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.

Founded: 2021
Employees: 52
Headquarters: Waltham, Massachusetts, United States
Website

⚡

Core Efficiency

ROE?

-12.50%

ROA?

-12.00%

D/E Ratio?

0.04

Op. Margin?

-6911.23%

📊

Profitability Ratios

Net Margin?

-6356.14%

Loading company sections...

Upstream Bio, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

The morning brief, before the bell.

Upstream Bio, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades